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Figure S1: CRH-regulated genes involved in estrogen signaling in MCF7 cells and in 
silico–predicted integrated network. (A to B) Analysis using the Human Estrogen 
Receptor Signaling in Breast Cancer RT² Profiler™ PCR Array and target-specific real-time 
RT-PCR. (A) Heat map of genes altered 24 hours after treatment with 100nM CRH 
compared with 1% acetic acid (control vehicle). The maximum expression of any given 
gene is shown in red; minimum expression is shown in green. Representative results from 
three independent biological replicates are shown. (B) Volcano plot of gene expression in 
(A), showing expression in response to CRH versus vehicle. Each circle in the plot 
represents one gene. Genes which are increased at least 2-fold are in red whereas the 
genes which are decreased at least 2-fold are in green; genes represented by black circles 
were not differentially regulated (P<0.05, paired Student’s t-test N=3). (C) In silico predicted 
integrated network of genes with significantly altered expression in response to CRH. ¥: 
genes identified as increased in ERα(+) breast tumors (55). ‡: genes whose expression is 
weakly inhibited by E2 in MCF7 cells (54). Solid lines denote distinct regulatory relationships 
as indicated, whereas dotted lines indicate predicted interactions. (D to F) Real-time RT-
PCR for (D) ESR1 and GPER, (E) ESR2, or (F) CRH-R1 and CRH-R2 in MCF7 cells 
stimulated with CRH as in (A). Data are mean ± SEM % or fold change relative to control or 
basal conditions against GAPDH expression from at least three independent biological 
replicates (*P<0.05, Mann-Whitney U test; N=3). 
  
  
Figure S2: Use of receptor antagonists to identify CRH-R subtypes mediating CRH effects 
in MCF7 cells. (A and B) Western blots for the phosphorylation of GSK3β at Ser9, Akt, and 
p38 in (A) MCF7 cells stimulated with CRH for 5 minutes and pre-treated with 1µM NBI 
(CRH-R1-specific antagonist), 1µM anti-sauvagine-30 (CRH-R2 antagonist) or vehicle 
(control) for 2 hours or (B) unstimulated cells. Data are mean ± SEM % change versus 
controls from at least three independent biological replicates (*P <0.05, Mann-Whitney U 
test; N=3). (C) Real-time RT-PCR for KRT18 and GNAS expression in MCF7 cells 
stimulated with 100nM CRH for 24hours and pre-treated with specific CRH-R antagonists 
as in (A) or vehicle. Data are mean ± SEM fold change relative to basal conditions, 
normalized to GAPDH, of at least three independent biological replicates (*P <0.05, paired 
Student’s t-test N=3). 
 
  
 Figure S3: CRH-regulated β-catenin expression in MCF7 cells. (A – C) Western blots with 
lysates from MCF7 cells treated with (A) 40 nM LiCl, (B)  100nM CRH for up to 120 min, or 
(C) 300nM sFRP1, 100nM CRH, or combined for 3 hours,. Immunoblots shown are 
representative of three independent experiments. Bar graphs show means ± SEM of % 
change relative to basal (untreated) of at least three independent biological replicates. (*P 
<0.05, Mann-Whitney U test; N=3; +P<0.05, Kruskal-Wallis ANOVA followed by Bonferoni 
test, N=3). 
 
  
 Figure S4: Kinetics of basal and CRH regulated MCF7 cell invasion. Kinetics of invasion 
was measured with the xCELLigence System. Cells were either treated with 1% acetic acid 
(control; squares) or treated with 100 nM CRH (circles), and invasion was measured over 
19 hours at frequent time intervals. Results shown are means ± SEM of the Cell Index 
curves of at least three independent biological replicates. 
 
  
 Figure S5: CRH-R1 and GPR30 mRNA and protein expression in MCF7 cells. (A) 
Conventional RT-PCR for CRH-R1α or CRH-R1(∆12) in MCF7 cells. PCR products 
were subsequently electrophoresed and visualized by ethidium bromide. 
Photomicrographs shown are representative of three independent experiments. (B) 
Confocal microscopy images of CRH-R1 in MCF7 cells transfected with or without 
CRH-R2 siRNA prior to stimulation with 100nM E2 for 24 hours. Photomicrographs 
shown are representative of three independent experiments. (C) Real time PCR of 
GPR30 expression from RNA isolated from MCF7 cells stimulated with E2. Data are 
mean ± SEM of % change versus control, normalized toGAPDH mRNA, from at least 
three independent biological replicates (*P<0.05, Mann-Whitney U test, N=3). 
Representative confocal microscopy images of GPR30 localization in MCF7 cells 
treated with E2 (inset, C). Photomicrographs shown are representative of three 
independent experiments. 
  
 Figure S6: Effect of knockdown of SRp55 on CRH- and E2-induced transcriptional 
effects in MCF7 cells. (A-B) Real time PCR of (A) KRT18 and GNAS or (B) CRH-R2 
expression in MCF7 cells transfected with or without SRSF6 siRNA prior to 
stimulation with either 100nM CRH for 24 hours (A) or 100nM E2 for 24 hours (B). 
Data are mean ± SEM fold change relative to control from at least three independent 
biological replicates, normalized to GAPDH expression. (*P<0.05, Mann-Whitney U 
test, N=3).  
  
Figure S7: Subcellular localization of SRp55 expression in E2-treated cells. 
Representative confocal microscopy images of immunofluorescent-labelled SRp55 
localization in MCF7 cells treated with or without 100nM E2 for 2 hours. Photomicrographs 
shown are representative of three independent experiments. 
